Brief: Alzinova Announces New Positive Safety Review Of Its Phase 1B Study In Alzheimer's Disease
07/09/2022 07:11
Sept 7 (Reuters) - Alzinova AB ALZ.ST :
* ALZINOVA ANNOUNCES NEW POSITIVE SAFETY REVIEW OF ITS PHASE
1B
STUDY IN ALZHEIMER'S DISEASE
* SECOND EXTERNAL SAFETY REVIEW HAS BEEN CARRIED OUT OF
COMPANY'S
CLINICAL PHASE 1B STUDY - WITH A POSITIVE ASSESSMENT TO CONTINUE
STUDY AS PLANNED
Source text for Eikon: ID:nWkr56YNBP
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alzinova AB
See all newsBrief: Alzinova's Board Resolves On Directed Issue Of Units
Brief: Alzinova Announces Preliminary Outcome Of The Rights Issue
Brief: Alzinova Broadens Shareholder Base With New Investor
Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln
Brief: Alzinova Q2 Loss After Financial Items At SEK 5.4 Million